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Abstract
Progression through the mammalian cell cycle is associated with the activity of four cyclin
dependent kinases (Cdc2/Cdk1, Cdk2, Cdk4, and Cdk6). Knockout mouse models have provided
insight into the interplay of these Cdks. Most of these models do not exhibit major cell cycle defects
revealing redundancies, and suggesting that a single Cdk might be sufficient to drive the cell cycle,
similar as in yeast. Recent work on Cdk2/Cdk4 double knockouts has indicated that these two Cdks
are required to phosphorylate Rb during late embryogenesis. The lack of Rb phosphorylation is
progressive and associated with reduced E2F-inducible gene expression. Cdk2 and Cdk4 share the
essential function of coupling the G1/S transition with mitosis. However, proliferation in early
embryogenesis appears to be independent of Cdk2 and Cdk4. We discuss these observations and
propose molecular mechanisms that establish the requirement for Cdk2 and Cdk4 at the G1/S
transition. We are considering that the balance between proliferation and differentiation is
disturbed, which affects especially heart development and leads to embryonic lethality in Cdk2-/-
Cdk4-/- mutants. We also discuss the specific functions of Cdk4 and Cdk6, which ironically do not
compensate for each other.
Background
Cell cycle regulation plays an essential role in cellular
homeostasis and contributes to determine the fate of cells.
Most factors influencing the decision, whether to start a
new round of division or not, act at the G1/S transition.
Mitogenic factors induce expression of cyclin D and there-
fore stimulate the activities of Cdk4 and Cdk6. The activa-
tion of the cyclin D/Cdk complexes is the first step leading
to cell cycle entry and is followed by several waves of cyc-
lin expression (cyclin E, cyclin A, and cyclin B). Each fam-
ily of cyclins binds to a specific Cdk, which is active at a
specific phase of the cell cycle and contributes to the acti-
vation of the next cyclin/Cdk complex. Recent studies in
different Cdk knockout mice have challenged this com-
mon model of mammalian cell cycle regulation. Single
loss of Cdk2, Cdk4, or Cdk6 did not significantly affect
cell proliferation in vivo or in vitro [1-4]. Among the most
surprising observations was the normal cell proliferation
in Cdk2 knockout mice, though Cdk2 was considered to
be a unique kinase bound to cyclin E, regulating S phase
initiation and progression. This perplexing observation
has been quickly addressed by further in vivo analysis
demonstrating that Cdc2, which was previously demon-
strated to control G2/M, is also able to bind cyclin E and
compensates for Cdk2 in S phase [5]. Similarly, inactiva-
tion of both Cdk4 and Cdk6 does not affect cell cycle ini-
tiation and progression, suggesting that Cdk2
compensates for the lack of cyclinD dependent kinases
[2]. More strikingly, the combined loss of Cdk6 and Cdk2
has no impact on cell proliferation and Cdk2-/-Cdk6-/- mice
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out mice [2]. These results suggest that a single G1/S phase
associated Cdk is sufficient to induce cell cycle entry and
progression through M phase. Based on this new knowl-
edge, the mammalian cell cycle might not be very differ-
ent from the yeast cell cycle, which is controlled by a
single Cdk (Cdc2 or Cdc28). Yet, the mammalian cell
cycle differs from the yeast cell cycle regarding the Rb/E2F
pathway, which is essential for G1/S control. The Rb pro-
tein cycles between hypo and hyper phosphorylated
forms and genes required for DNA replication and mitosis
are repressed when E2F transcription factors are bound to
hypophosphorylated Rb. Rb is a major substrate for Cdks
and upon its phosphorylation, E2F proteins are released,
which acts as an on/off switch for entry into S phase. Until
recently, major Rb phosphorylation defects have never
been observed in any of the "Cdk" or "cyclin" knockout
mice. In vitro, it was shown that Cdk4, Cdk6, and Cdk2
phosphorylate Rb at different sites (for review, see [6]),
but in vivo, one of these Cdks could be sufficient to
accomplish Rb phosphorylation. We will discuss this
hypothesis in reference to recent observations made in
Cdk2-/-Cdk4-/- mice and provide new models of mamma-
lian cell cycle regulation.
Cdk2 and Cdk4 cooperate to couple the G1/S 
transition with mitosis
We recently generated Cdk2/Cdk4 double knockout
(DKO) mice and for the first time we observed reduced Rb
phosphorylation in vivo and in vitro [7]. The decrease of
Rb phosphorylation is progressive and does not occur
before E13.5 during embryonic development. Rb protein
levels are similar in wild type and DKOs, but phosphor-
ylation at Serine 780 is decreased at E14.5 and barely
detectable at E16.5. As a likely consequence, all embry-
onic tissues tested display a significant lower proliferation
rate at E14.5. However, we still observed a high rate of
overall proliferation in most tissues (i.e. lung, liver), sug-
gesting that some cell subpopulations might be more
affected than others. To better understand the molecular
mechanism, we analyzed mouse embryonic fibroblasts
(MEFs) and were able to correlate the lack of Rb phospho-
rylation with impaired S phase entry and premature senes-
cence. The primary cause of the proliferation defect is
associated with Rb hypophosphorylation and decreased
expression of E2F-inducible genes, among them Cdc2 and
cyclin A2. On the other hand, HPV-E7-mediated inactiva-
tion of Rb restored normal expression of E2F-inducible
genes and cell proliferation. This result suggests that Cdk6
and Cdc2 can regulate cell proliferation, but these two
kinases might not phosphorylate Rb to full extent, leading
to decreased Cdc2 expression. The declining Cdc2 expres-
sion acts as a negative loop leading to proliferation
defects. The fact that more Cdk6 is bound to cyclin D1, in
the absence of Cdk4, is apparently not sufficient to com-
pensate the lack of Cdk2 and Cdk4 (see below). From our
experiments, we conclude that Cdk2 or Cdk4 is required,
at a certain point, to phosphorylate Rb thereby maintain-
ing higher levels of Cdc2 protein expression. These two
G1/S kinases contribute to the activation of G2/M cyclin/
Cdk complexes, and doing so, couple the G1/S transition
with mitosis. Characterization of the double knockout
mice of Cdk2 and Cdk4 revise the picture of the cell cycle,
combining features from the classic mammalian model
and features from the yeast model. Nevertheless, though
we have uncovered the dynamics of this molecular mech-
anism, we still need to understand why Rb phosphoryla-
tion starts to decline only at midgestation.
Why Cdc2 does not compensate for Cdk2 in late 
embryogenesis?
The late embryonic lethality of DKOs suggest that Cdk2
and Cdk4 are required to regulate the Rb/E2F pathway
only late in development. In agreement with this, cell pro-
liferation in early embryogenesis is comparable in DKO
and wild type embryos. Our analysis has shown that Rb
phosphorylation decreases progressively after E13.5, and
we can only speculate how Rb phosphorylation is main-
tained in early development. Therefore, we propose four
possible models that are not mutually exclusive and can
possibly explain our findings (Figure 1). The first possibil-
ity (Figure 1B) could be that in early embryogenesis, stem
cell and early progenitor cell proliferation is not control-
led by Rb and other pocket proteins (p107, p130). It has
been shown that proliferation of embryonic stem (ES)
cells is not affected by concomitant ablation of all three
pocket proteins, whereas similar mutant MEFs proliferate
faster than wild type MEFs and loose G1 control [8,9]. On
the other hand, Rb appears to be immediately phosphor-
ylated, and therefore inactivated, after completion of
mitosis in ES cells, while the unphosphorylated form is
observed at the onset of G1 phase in MEFs [10]. Moreover,
cyclin D/Cdk4 associated kinase activity is undetectable
and low levels of cyclin E/Cdk2 complexes are expressed
in ES cells, consistent with an apparent lack of Rb regula-
tion in ES cells [11]. As previously suspected, we can envi-
sion that in ES cells, there is a specific mechanism that
triggers the inactivation of Rb and other pocket proteins.
It could be a specific kinase, the absence of a phosphatase,
the degradation of the pocket proteins, or simply an
increased activity of Cdc2 (or Cdk6) in ES cells. This
mechanism could be maintained through the early stages
of embryogenesis and consequently the lack of Cdk2 and
Cdk4 would have no effect until pocket proteins become
active and repress E2F proteins. Our second model (Figure
1C) is based on exponential dynamics: at each cell divi-
sion, the combined activities of Cdk6 and Cdc2 phospho-
rylate Rb but are not 100% efficient. The lack of efficiency
might not be noticeable in early stages of embryogenesis,
but after a number of cell divisions, Rb phosphorylationPage 2 of 6
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Coupling of G1/S transition with mitosisFig re 1
Coupling of G1/S transition with mitosis. Cell proliferation appears to be dependent on Cdk2 and Cdk4 in late embryo-
genesis but not in early embryogenesis. (A) Previous results suggested that phosphorylation of Rb is differently regulated in 
stem cells and in differentiated cells [10, 11]. The characterization of Cdk2-/-Cdk4-/- mice demonstrates Cdk2 and Cdk4 inde-
pendence for Rb phosphorylation in early embryogenesis and we proposed four models for the G1/S transition and the estab-
lishment of Cdk2/Cdk4 dependent Rb/E2F checkpoint. These molecular mechanisms are not exclusive and they might all play a 
role throughout the differentiation process or in specific cell types. (B) Specific kinases or phosphatases are differentially 
expressed in stem cells or differentiated cells, which modifies the phosphorylation of Rb. Cdc2 could be also more active in 
stem cells. (C) Cdk6 and Cdc2 do not phosphorylate Rb to full extend, which progressively affects the E2F-dependent tran-
scription of Cdc2 and initiates a negative feedback loop. (D) Proteins promoting differentiation at the onset of the G1phase. 
Throughout the differentiation process, the length of G1phase extends, tipping the balance between proliferation and differen-
tiation towards cell cycle exit and further differentiation. Unphosphorylated Rb itself is a major inducer of the cell cycle exit. 














































































































P P P P
A
early embryogenesis
(stem cells, early progenitors)
late embryogenesis
(late progenitors, differentiated cells)
Cell Division 2006, 1:10 http://www.celldiv.com/content/1/1/10might fall below a threshold level, required to maintain
high levels of Cdc2 expression. Consequently, low Cdc2
expression might affect noticeably the phosphorylation of
Rb in the next round of cell division, thereby triggering the
amplification of the negative loop. Our third model (Fig-
ure 1D) is based on the difference in G1 phase length
between stem cells and differentiated cells. Indeed, the
cell cycle length of stem cell is about 8 hours long, where
as the differentiated cells take about of 20–24 hours to
complete one cycle. This difference is mainly associated
with a longer G1 phase that increases throughout the dif-
ferentiation process. It is possible that Cdk6 and Cdc2 can
completely phosphorylate Rb when G1 phase is short, but
when the length of this phase extends their efficiency may
drop. In this model, Cdc2 might not be active during early
G1 to contribute with Cdk6 to the phosphorylation of Rb.
Rb represses E2F and therefore S phase gene transcription
during G1 phase, but on the other hand activates tran-
scription in concert with other transcription factors (i.e.
MyoD in myogenesis – for review, see [12]), and contrib-
utes to cell differentiation and cell cycle exit [13]. If Cdk
activity is not high enough throughout the G1 phase, this
balance might be shifted in favor of differentiation rather
than proliferation. With an extended G1 phase, Cdk6 and
Cdc2 might not be able to counteract the proteins induc-
ing differentiation, even in the presence of growth factors.
A fourth option (Figure 1E) is associated with the inhibi-
tors of Cdks, p21 and p27. The combined loss of Cdk2
and Cdk4 most likely affects the distribution of these
inhibitors since in wild type cells the majority of p27 is
bound to Cdk4. Indeed, the inactivation of Cdk4 or Cdk2
induces relocation of free p27 to Cdk2 or Cdc2 complexes
respectively, which affects their activity. Studies with p27
knockout mice have shown that loss of p27 can rescue a
normal entry of S phase in Cdk4-null [4] or Cdk2-null
MEFs (unpublished data). In Cdk2-/-Cdk4-/- DKO, these
inhibitors might be relocated to Cdc2 complexes and
therefore, through their inhibition, contribute to the lack
of Rb phosphorylation. We tested this hypothesis by
knocking out p27 in Cdk2-/-Cdk4-/- mice, but did not
observe a rescue of embryonic lethality or proliferation of
MEFs [7]. This result suggests that Cdk inhibitors, at least
p27, are not responsible for Rb hypophosphorylation and
proliferation defects in DKOs. To discriminate between
these models, further studies will be necessary. Such stud-
ies could be done using stem cells, where proliferation
and differentiation can be monitored, or by identification
of molecular pathways that can rescue the lack of Rb phos-
phorylation. To address this, we have tried to overexpress
Cdc2 in Cdk2-/-Cdk4-/- MEFs but Cdc2 did not restore nor-
mal proliferation (unpublished data).
Origin of Cdk2-/-Cdk4-/- embryonic lethality
The embryonic lethality in DKOs is most likely associated
with cardiac failure. The small size of the Cdk2-/-Cdk4-/-
embryos is probably linked to the progressive loss of Rb
phosphorylation observed at midgestation. So far, we do
not know if the heart defect is related to hypophosphor-
ylation of Rb. A similar cardiac phenotype was observed
in cyclin D1-/-D2-/-D3-/- triple knockouts [14]. It is likely
that a common molecular mechanism affects the heart
defects in cyclin D-null and Cdk2-/-Cdk4-/- mice. Cyclin D-
null mice do not display an Rb defect, however, it cannot
be excluded that the Rb/E2F pathway is deregulated in cyc-
lin D-null cardiomyocytes. This pathway plays a major
role in cardiogenesis and the levels of free activated E2F is
critical for normal cardiac function [15]. Another example
of the strong Rb/E2F dependence in heart development is
that hypophosphorylated Rb binds to a transcriptional
repressor of cardiac specific genes, Jumonji [16]. The inac-
tivation of Jumonji affects embryonic heart development
and, in vitro, results in upregulation of cyclin D1 and
Cdc2 levels, and increased cardiomyocyte proliferation
[16]. From E11.5 to E14.5, cardiomyocytes proliferate
rapidly, leading to expansion of the ventricular wall. In
the heart of Cdk2-/-Cdk4-/- mutants, Rb represses E2Fs,
probably interacting with repressors like Jumonji, which
then inhibits cardiomyocyte growth. Further characteriza-
tion of this pathway might help to better understand the
complexity of heart development and the relation to the
cell cycle players. Studies of Cdk2-/-Cdk4-/- cardiomyocytes
will be a good experimental model to determine how the
combined loss of Cdk2 and Cdk4 affects the balance
between differentiation and proliferation. We need to
determine why the cardiogenesis is more sensitive to inac-
tivation of Cdk2 and Cdk4 than differentiation of other
cell types.
Cdk4 and Cdk6: similar kinases but not twins
Studies with double knockout mouse models have
pointed out some differences between Cdk4 and Cdk6.
Indeed Cdk2-/-Cdk4-/- mutants are embryonic lethal,
whereas Cdk2-/-Cdk6-/- mice develop normally. Focusing
on animal growth and control of cell proliferation, several
observations suggest that Cdk4 and Cdk6 do not com-
pletely compensate for each other in vivo. Cdk4 single
knockout males and females display reduced animal size
[3,4], while inactivation of Cdk6 reduces the size of the
females but to a lesser extend than Cdk4 mutation [2]. At
the cellular level, S phase entry is delayed in Cdk4-null but
not in Cdk6-null MEFs [2-4]. Moreover and in contrast to
Cdk6, Cdk4 is able to promote a normal S phase entry in
MEFs, in the absence of the other G1/S Cdks. This differ-
ence in the cell cycle regulation could be related to the
reduced size of Cdk4-/- and Cdk2-/-Cdk4-/- mutants com-
pared to wild type or Cdk2-/-Cdk6-/- mutants. The complete
inactivation of Cdk4 and Cdk2 leads to more pronounced
lack of proliferation (at least in the hematopoietic linage
and in MEFs) and affects cardiac development, thereby
inducing embryonic lethality [7].Page 4 of 6
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described between Cdk4 and Cdk6 (for review, see [17]).
In vivo, subtle differences in timing or pattern of expres-
sion could explain the divergence in phenotype of corre-
sponding null animals (i.e. Cdk4 affects β-islet pancreatic
cells, Cdk6 is involved lymphocyte T proliferation [2,3]).
However, Cdk4 and Cdk6 are widely expressed in
embryos and their expression is similar in most of the cell
types, suggesting that these two kinases might be distinct
regarding their substrate specificity. It has been shown
that Cdk4 is more efficient in phosphorylating Rb than
Cdk6 and displays different residue selectivity [18]. This
result needs to be confirmed in vivo and could explain our
observations in Cdk2-/-Cdk4-/- mice. Other substrates
might also be involved, such as Smad3, phosphorylated
by Cdk4 and Cdk2 but not yet tested for Cdk6 [19].
Smad3 mediates growth inhibitory effects of TGFβ by
upregulating the expression of Cdk inhibitors. Cdk4 and
Cdk2 phosphorylate Smad3 and inhibit Smad3 antipro-
liferative function, providing negative feedback control.
The lack of Cdk4 and Cdk2 might amplify this antiprolif-
erative signal. Such crosstalk between cell cycle regulation
and upstream signaling could affect the G1/S transition
differently through Cdk4 or Cdk6. Moreover, recent find-
ings suggest a new role for Cdk6 in the differentiation of a
variety of cell types. This function, which affects the tran-
scription of genes involved in terminal differentiation, is
not shared with Cdk4 and could be independent of Rb
(for review, see [17]). All these evidences gathered
recently suggest that Cdk4 and Cdk6 may have independ-
ent functions in the maintenance of the delicate balance
between cellular division and differentiation.
Conclusion
Our knowledge of cell cycle regulation has greatly
improved through the characterization of knockout
mouse models. The overlap of Cdk functions adds more
complexity to the in vitro model of the cell cycle (specific
Cdk/cyclin complexes for each cell cycle phase). On the
other hand, we can consider that all Cdks are redundant,
which would result in a model similar to the yeast cell
cycle. Our recent results show that the redundancy is not
complete and each Cdk might have its own niche. This
specificity could be essential for small subpopulations of
cells (β-islet pancreatic cells for Cdk4, spermatocytes for
Cdk2...) or affect cell cycle regulation globally. Indeed,
Cdk2 and Cdk4 share a common role in the G1/S transi-
tion, which couples this phase with mitosis through E2F-
inducible gene expression. Embryonic stem cells might
proliferate independently of this coupling, and we pre-
sented four models to describe how this coupling can take
place during embryogenesis. Among E2F-inducible genes,
we focused on the role that Cdc2 can play as a kinase to
phosphorylate Rb, however we cannot exclude that other
E2F-targets are also important. Moreover, these four
molecular mechanisms act probably in concert to estab-
lish the G1/S checkpoint. This role might be important
with regards to cancer cells. Could the combined targeting
of Cdk2 and Cdk4 be a valuable approach for cancer ther-
apy? To answer this question, we have to determine if Rb
wild type cancer cells require Cdk2 and Cdk4 activities
throughout tumor progression. Future experiments with
the Cdk2-/-Cdk4-/- mouse model will teach us more details
about tumorigenesis.
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